MARÍA
SALAZAR ROA
Ramón y Cajal
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (2)
2023
-
miR-203 drives breast cancer cell differentiation
Breast Cancer Research, Vol. 25, Núm. 1
2016
-
The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase
Clinical Cancer Research, Vol. 22, Núm. 10, pp. 2508-2519